These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 36441595)

  • 21. Value of markers of systemic inflammation for the prediction of postoperative progression in patients with pancreatic neuroendocrine tumors.
    Yang L; Fu M; Yu L; Wang H; Chen X; Sun H
    Front Endocrinol (Lausanne); 2024; 15():1293842. PubMed ID: 38370351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI).
    Mandaliya H; Jones M; Oldmeadow C; Nordman II
    Transl Lung Cancer Res; 2019 Dec; 8(6):886-894. PubMed ID: 32010567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High neutrophil-to-lymphocyte ratios confer poor prognoses in patients with small cell lung cancer.
    Liu D; Huang Y; Li L; Song J; Zhang L; Li W
    BMC Cancer; 2017 Dec; 17(1):882. PubMed ID: 29268698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pretreatment PLR Is Preferable to NLR and LMR as a Predictor in Locally Advanced and Metastatic Bladder Cancer.
    Karan C; Yaren A; Demirel BC; Dogan T; Ozdemir M; Demiray AG; Taskoylu BY; Degirmencioglu S; Dogu G; Ozhan N; Cakiroglu U; Celikyurek A
    Cancer Diagn Progn; 2023; 3(6):706-715. PubMed ID: 37927800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic value of preoperative inflammatory markers in patients with glioma: a multicenter cohort study.
    Zheng SH; Huang JL; Chen M; Wang BL; Ou QS; Huang SY
    J Neurosurg; 2018 Sep; 129(3):583-592. PubMed ID: 29099300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of preoperative neutrophil-lymphocyte, lymphocyte-monocyte, and platelet-lymphocyte ratios in patients with upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy.
    Song X; Zhang GM; Ma XC; Luo L; Li B; Chai DY; Sun LJ
    Onco Targets Ther; 2016; 9():1399-407. PubMed ID: 27042108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as prognostic markers in patients with extensive-stage small cell lung cancer treated with atezolizumab in combination with chemotherapy.
    Kutlu Y; Aydin SG; Bilici A; Oven BB; Olmez OF; Acikgoz O; Hamdard J
    Medicine (Baltimore); 2023 Apr; 102(15):e33432. PubMed ID: 37058061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of immune inflammatory indices and nutritional risk index with prognosis in patients with non-small cell lung cancer.
    Shi Z; Zheng D; Tang X; Du Y
    Am J Transl Res; 2023; 15(6):4100-4109. PubMed ID: 37434819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer.
    Shao N; Cai Q
    Clin Transl Oncol; 2015 Oct; 17(10):772-8. PubMed ID: 26243392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of changes in neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and lymphocyte-to-monocyte ratio (LMR) for patients with cervical cancer undergoing definitive chemoradiotherapy (dCRT).
    Trinh H; Dzul SP; Hyder J; Jang H; Kim S; Flowers J; Vaishampayan N; Chen J; Winer I; Miller S
    Clin Chim Acta; 2020 Nov; 510():711-716. PubMed ID: 32919942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative platelet-lymphocyte ratio is a superior prognostic biomarker to other systemic inflammatory response markers in non-small cell lung cancer.
    Huang Q; Diao P; Li CL; Peng Q; Xie T; Tan Y; Lang JY
    Medicine (Baltimore); 2020 Jan; 99(4):e18607. PubMed ID: 31977852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined prognostic value of the SUVmax derived from FDG-PET and the lymphocyte-monocyte ratio in patients with stage IIIB-IV non-small cell lung cancer receiving chemotherapy.
    Zhao K; Wang C; Shi F; Huang Y; Ma L; Li M; Song Y
    BMC Cancer; 2021 Jan; 21(1):66. PubMed ID: 33446134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does Preoperative Serum Neutrophil to Lymphocyte Ratio (NLR), Platelet to Lymphocyte Ratio (PLR), and Lymphocyte to Monocyte Ratio (LMR) Predict Prognosis Following Radical Surgery for Pancreatic Adenocarcinomas? Results of a Retrospective Study.
    Gupta V; Chaudhari V; Shrikhande SV; Bhandare MS
    J Gastrointest Cancer; 2022 Sep; 53(3):641-648. PubMed ID: 34406625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, lymphocyte-to-monocyte ratio and prognostic nutritional index for predicting clinical outcomes in T1-2 rectal cancer.
    Xia LJ; Li W; Zhai JC; Yan CW; Chen JB; Yang H
    BMC Cancer; 2020 Mar; 20(1):208. PubMed ID: 32164623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic Value of Neutrophil:Lymphocyte and Platelet:Lymphocyte Ratios for 28-Day Mortality of Patients with AECOPD.
    Luo Z; Zhang W; Chen L; Xu N
    Int J Gen Med; 2021; 14():2839-2848. PubMed ID: 34211292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammatory biomarkers predict outcomes of patients with radioactive iodine refractory thyroid cancer treated with sorafenib.
    Jin M; Kim M; Jeon MJ; Kim EY; Shin DY; Kim BH; Kim WB; Shong YK; Lim DJ; Kim WG
    Endocrine; 2023 Aug; 81(2):298-305. PubMed ID: 36928602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of the lymphocyte-to-monocyte ratio in patients with malignant pleural mesothelioma.
    Yamagishi T; Fujimoto N; Nishi H; Miyamoto Y; Hara N; Asano M; Fuchimoto Y; Wada S; Kitamura K; Ozaki S; Kishimoto T
    Lung Cancer; 2015 Oct; 90(1):111-7. PubMed ID: 26259877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prognostic impact of neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) in patients with distal bile duct cancer.
    Miyahara Y; Takashi S; Shimizu Y; Ohtsuka M
    World J Surg Oncol; 2020 Apr; 18(1):78. PubMed ID: 32321522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Association of the Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, Lymphocyte-to-Monocyte Ratio and Systemic Inflammation Response Index with Short-Term Functional Outcome in Patients with Acute Ischemic Stroke.
    Zhang YX; Shen ZY; Jia YC; Guo X; Guo XS; Xing Y; Tian SJ
    J Inflamm Res; 2023; 16():3619-3630. PubMed ID: 37641703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic implications of neutrophil-to-lymphocyte ratio in patients with extensive-stage small cell lung cancer receiving chemoimmunotherapy: A multicenter, real-world study.
    Bi H; Ren D; Xiao Y; Zhou Y; Yi B; Han W; Shao Y; Wang J; Zhang C; Wang H
    Thorac Cancer; 2024 Mar; 15(7):559-569. PubMed ID: 38294282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.